Literature DB >> 3108011

Flecainide--an intravenous infusion regimen.

J C Cowan, D W Holt, R S Bexton, D S Reid.   

Abstract

An intravenous infusion regimen for flecainide was studied in 12 patients. Therapeutic drug levels were rapidly established and maintained throughout the 48-h infusion period. Two patients were withdrawn because of possible drug related problems, but in general the regimen seemed both effective and well tolerated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108011     DOI: 10.1007/bf00542195

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  Flecainide acetate.

Authors: 
Journal:  Lancet       Date:  1984-01-14       Impact factor: 79.321

2.  Prophylaxis of primary ventricular fibrillation in acute myocardial infarction. The case against lignocaine.

Authors:  P Kertes; D Hunt
Journal:  Br Heart J       Date:  1984-09

3.  High-performance liquid chromatographic method for the measurement of mexiletine and flecainide in blood plasma or serum.

Authors:  R K Bhamra; R J Flanagan; D W Holt
Journal:  J Chromatogr       Date:  1984-05-11

4.  Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram.

Authors:  J Morganroth; L N Horowitz
Journal:  Am J Cardiol       Date:  1984-02-27       Impact factor: 2.778

5.  Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease.

Authors:  V Legrand; M Vandormael; P Collignon; H E Kulbertus
Journal:  Am J Cardiol       Date:  1983-02       Impact factor: 2.778

6.  Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate.

Authors:  A W Nathan; K J Hellestrand; R S Bexton; S O Banim; R A Spurrell; A J Camm
Journal:  Am Heart J       Date:  1984-02       Impact factor: 4.749

7.  The haemodynamic effect of intravenous flecainide acetate in patients with coronary artery disease.

Authors:  P W Serruys; G Vanhaleweyk; M Van Den Brand; P Verdouw; J Lubsen; P G Hugenholtz
Journal:  Br J Clin Pharmacol       Date:  1983-07       Impact factor: 4.335

Review 8.  Metabolism of flecainide.

Authors:  G J Conard; R E Ober
Journal:  Am J Cardiol       Date:  1984-02-27       Impact factor: 2.778

Review 9.  Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  B Holmes; R C Heel
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

10.  Flecainide pharmacokinetics in healthy volunteers: the influence of urinary pH.

Authors:  A Johnston; S Warrington; P Turner
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.